N-[4-(2-Pyridinyl)benzoyl]glycine-13C2,15N

Modify Date: 2024-04-10 20:52:15

N-[4-(2-Pyridinyl)benzoyl]glycine-13C2,15N structure	Common Name	N-[4-(2-Pyridinyl)benzoyl]glycine-13C2,15N
	CAS Number	1391053-26-1	Molecular Weight	259.24
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₁₂₁₃C₂H₁₂N₁₅NO₃	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of N-[4-(2-Pyridinyl)benzoyl]glycine-13C2,15N

N-[4-(2-Pyridinyl)benzoyl]glycine-13C2,15N is a 15N-labeled and 13C-labled labeled N-[4-(2-Pyridinyl)benzoyl]glycine[1].

Name	N-[4-(2-Pyridinyl)benzoyl]glycine-13C2,15N

Description	N-[4-(2-Pyridinyl)benzoyl]glycine-13C2,15N is a 15N-labeled and 13C-labled labeled N-[4-(2-Pyridinyl)benzoyl]glycine[1].
Related Catalog	Research Areas >> Others Signaling Pathways >> Others >> Others
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[72].
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223.

Molecular Formula	C₁₂₁₃C₂H₁₂N₁₅NO₃
Molecular Weight	259.24